How many units is 2.5 mg of tirzepatide on a U-100 insulin syringe?

50 units at 5 mg/mL, 25 units at 10 mg/mL, 12 to 13 units at 20 mg/mL, 6 to 7 units at 40 mg/mL. The unit number is the mL volume times 100.

Is the 2.5 mg starting dose enough to lose weight?

Most people see appetite suppression begin at 2.5 mg, but the weight loss data in the SURMOUNT trials came from the higher doses. 2.5 mg is a tolerance-building step, not a maintenance dose.

Can people over 50 use tirzepatide for weight loss?

Yes. The SURMOUNT-1 trial enrolled adults up to age 75, and the FDA label has no upper age cutoff. Older adults need closer monitoring for dehydration if GI side effects appear, and for any change in kidney function during titration.

Is tirzepatide the same as Ozempic?

No. Ozempic is semaglutide, a single GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors. In head-to-head data, tirzepatide produces larger weight loss at maximum doses than semaglutide does at maximum doses.

Can I use tirzepatide with metformin?

Tirzepatide is commonly prescribed alongside metformin for type 2 diabetes. The combination does not require a tirzepatide dose adjustment. Talk to your prescriber before combining with any insulin or sulfonylurea since hypoglycemia risk rises.

What if the syringe mark for my calculated dose is between two unit lines?

Round to the nearest whole unit. The clinical difference between 12 and 13 units at 20 mg/mL is 0.2 mg of tirzepatide, well within the dose-response noise. Pick one direction and stay consistent week to week.

Does it matter where I inject?

All three standard sites (abdomen, thigh, upper outer arm) produce equivalent absorption. Rotate sites to reduce local skin and fat tissue irritation. Many people stay with the abdomen because it is easiest to pinch and the needle is least uncomfortable there.

How do I store a compounded tirzepatide vial?

Refrigerate at 36 to 46 degrees Fahrenheit. Do not freeze. Once opened, most compounded vials are stable for 28 to 56 days depending on the pharmacy. Check the beyond-use date your pharmacy printed on the label, not a generic value from an online source.

My compounded vial concentration changed at refill. What do I do?

Stop. Do not draw the same number of units you drew last week. Re-do the math with the new concentration printed on the new label. If you are unsure, call the pharmacy and ask them to confirm the new units value for your prescribed mg dose.

How Many mL Is 2.5 mg of Tirzepatide?

Summary: For compounded tirzepatide at 5 mg/mL the answer is 0.5 mL, which reads as 50 units on a U-100 insulin syringe. For other concentrations the math changes, and getting it wrong is the most common reason people underdose or overdose.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: 2.5 mg of tirzepatide is 0.5 mL when the vial is labeled 5 mg/mL. On a standard U-100 insulin syringe that is 50 units. That covers most compounded tirzepatide on the market, but it only covers the 5 mg/mL version. If your vial is a different concentration, the volume changes, the units change, and the syringe mark you draw to changes with them.

Below is the full table, the math behind it, and the safety details that matter when you draw your own dose.

The fast answer for the most common concentrations

Vial concentration	mL for 2.5 mg	U-100 insulin syringe units
5 mg/mL	0.5 mL	50 units
10 mg/mL	0.25 mL	25 units
15 mg/mL	0.167 mL	17 units (round)
20 mg/mL	0.125 mL	12 to 13 units
30 mg/mL	0.083 mL	8 units (round)
40 mg/mL	0.0625 mL	6 units (round)

Brand pens are different. Mounjaro and Zepbound 2.5 mg pens are pre-filled at 2.5 mg per 0.5 mL ^[1]^[2]. You do not measure anything. You press the button and the pen delivers the whole 0.5 mL. The math here only matters if you have a multi-dose compounded vial and you are drawing from it with an insulin syringe.

The math

Two formulas, that is the whole system.

mL = milligrams desired / concentration in mg/mL
units (U-100) = mL × 100

A U-100 insulin syringe is calibrated so that 100 units equals 1 mL. That is the only kind of insulin syringe most pharmacies stock, so the unit number you draw to is the volume in mL times 100.

Worked example. You have a vial at 10 mg/mL and your prescribed dose is 2.5 mg.

mL = 2.5 / 10 = 0.25 mL
units = 0.25 × 100 = 25 units

You draw to the 25 mark. That is your dose.

Worked example with a fractional unit. Vial at 20 mg/mL, dose 2.5 mg.

mL = 2.5 / 20 = 0.125 mL
units = 12.5

Insulin syringes do not have a 12.5 mark. The hash marks on a 1 mL U-100 syringe are at every full unit. You round to 12 or 13. Talk to your prescriber about which way to round, and stay consistent week to week. A swing between 12 and 13 means a swing between 2.4 mg and 2.6 mg, which is not a clinically meaningful change for tirzepatide, but you want consistency from one injection to the next so your titration data is comparable.

Why concentration is the variable that ruins everything

Compounding pharmacies do not all ship tirzepatide at the same strength. A 1 mL vial labeled 10 mg/mL holds 10 mg total. A 2 mL vial labeled 20 mg/mL holds 40 mg total. Both might cost roughly the same, both might look identical sitting next to each other in your fridge, and both will give you a wildly different dose if you draw the same number of units.

If you trained on a 5 mg/mL vial at 50 units per dose and then switched to a 10 mg/mL vial without updating the math, those 50 units now deliver 5 mg of tirzepatide, which is double your prescription. That is the textbook overdose path. The reverse happens too. Someone on a 10 mg/mL protocol switching to a 5 mg/mL refill and drawing 25 units injects 1.25 mg instead of 2.5 mg and wonders why their appetite suppression vanished.

The number on the vial label is the only number that matters for this math. Not the brand. Not what your friend uses. Not what the calculator from six months ago told you. Read the label every dose.

What 2.5 mg of tirzepatide actually does at this dose

The 2.5 mg starting dose exists for tolerance, not for results. Lilly designed the titration protocol around the well-documented fact that tirzepatide's main side effects, primarily nausea and vomiting, are dose dependent. Starting at 2.5 mg and stepping up by 2.5 mg every four weeks gives the gut time to adapt to slowed gastric emptying. People who try to skip ahead to therapeutic doses almost always quit early because the GI side effects overwhelm them.

In the SURMOUNT-1 trial that supported Zepbound's approval for weight loss, the 2.5 mg dose was treated as a four-week initiation period and was not analyzed as a maintenance dose ^[4]. Weight loss results came from the 5 mg, 10 mg, and 15 mg arms. So 2.5 mg is what you draw for weeks 1 through 4. After that you escalate. The same conversion math applies at every dose, you just change the milligram number.

Inverse conversion: how many mg is 20 units of tirzepatide?

This question shows up in pharmacy phone calls all the time. The answer is the same math, inverted. With a 5 mg/mL vial, 20 units equals 0.2 mL equals 1.0 mg of tirzepatide. With a 10 mg/mL vial, 20 units equals 0.2 mL equals 2.0 mg. With a 20 mg/mL vial, 20 units equals 4.0 mg. So 20 units is not a dose, it is a volume, and the dose depends entirely on the vial.

Vial concentration	20 units delivers
5 mg/mL	1.0 mg
10 mg/mL	2.0 mg
15 mg/mL	3.0 mg
20 mg/mL	4.0 mg
40 mg/mL	8.0 mg

If your prescription card says 2.5 mg and the syringe reading you wrote down last week was 20 units, those two numbers can only both be correct if you are on a 12.5 mg/mL vial. Anything else means a mistake somewhere. Call your pharmacy.

Brand pens versus compounded vials

There is no math to do with a Mounjaro or Zepbound pen. Lilly ships six different pen strengths for tirzepatide: 2.5, 5, 7.5, 10, 12.5, and 15 mg ^[3]. Each pen contains 0.5 mL of solution at the matching concentration for one dose. You attach a needle, dial nothing, press the button, count to ten, withdraw. The volume question never comes up.

The math comes back when:

A compounding pharmacy ships a multi-dose vial because brand pens are out of stock or out of budget. This was extremely common during the 2024 to 2025 shortage that put tirzepatide on the FDA shortage list, and it is still common for cash-pay patients.
You buy a research-grade vial from a peptide supplier and reconstitute it yourself. The supplier ships a lyophilized powder, you add bacteriostatic water, and the final concentration depends on how much water you added. Many supplier guides default to 5 mg/mL because that matches the brand pen ratio and keeps the math identical to clinical references.
A pharmacy switches you from one concentration to another between refills without flagging it. This is the silent failure mode that injures people who otherwise know what they are doing.

Oral tirzepatide does not exist as an FDA-approved product. Lilly has run trials on oral GLP-1 and dual GIP/GLP-1 candidates, but as of 2026 every tirzepatide formulation on the legal US market is subcutaneous. If a website is selling "tirzepatide oral drops" or sublingual tirzepatide, the active ingredient is not validated to absorb that way, the dosing is not based on published clinical data, and the math on this page does not apply.

Drawing the dose, step by step

Wash your hands.
Pull the vial from the fridge and let it warm at room temperature for a few minutes. Cold tirzepatide stings going in more than tirzepatide at room temperature.
Wipe the rubber stopper with an alcohol pad.
Pull back the syringe plunger to the unit mark you calculated. Some people prefer to inject this air into the vial first to make it easier to draw the liquid; others skip that step. Either works for compounded vials with a flexible rubber stopper.
Invert the vial, insert the needle, draw to the target unit mark. Flick out any air bubble and re-draw to the exact line.
Choose an injection site. Stomach, thigh, or upper outer arm are all standard subcutaneous sites. Rotate sites between weekly doses; the same spot in the same week is fine, but injecting into the same square inch every Sunday for six months risks fat tissue changes. Many people find the abdomen most comfortable. Pick a spot at least two inches from the navel, pinch the skin gently if you are lean, insert at 90 degrees, push the plunger steady and slow, count to five, withdraw.
Cap the needle into a sharps container. Do not recap with your fingers.
Write down the date, the dose in mg, and the syringe unit number you drew. A simple log on the fridge catches your future dosing errors before they happen.

Common questions about 2.5 mg dosing

How many units is 2.5 mg of tirzepatide on a U-100 insulin syringe?: 50 units at 5 mg/mL, 25 units at 10 mg/mL, 12 to 13 units at 20 mg/mL, 6 to 7 units at 40 mg/mL. The unit number is the mL volume times 100.
Is the 2.5 mg starting dose enough to lose weight?: Most people see appetite suppression begin at 2.5 mg, but the weight loss data in the SURMOUNT trials came from the higher doses. 2.5 mg is a tolerance-building step, not a maintenance dose.
Can people over 50 use tirzepatide for weight loss?: Yes. The SURMOUNT-1 trial enrolled adults up to age 75, and the FDA label has no upper age cutoff. Older adults need closer monitoring for dehydration if GI side effects appear, and for any change in kidney function during titration.
Is tirzepatide the same as Ozempic?: No. Ozempic is semaglutide, a single GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors. In head-to-head data, tirzepatide produces larger weight loss at maximum doses than semaglutide does at maximum doses.
Can I use tirzepatide with metformin?: Tirzepatide is commonly prescribed alongside metformin for type 2 diabetes. The combination does not require a tirzepatide dose adjustment. Talk to your prescriber before combining with any insulin or sulfonylurea since hypoglycemia risk rises.
What if the syringe mark for my calculated dose is between two unit lines?: Round to the nearest whole unit. The clinical difference between 12 and 13 units at 20 mg/mL is 0.2 mg of tirzepatide, well within the dose-response noise. Pick one direction and stay consistent week to week.
Does it matter where I inject?: All three standard sites (abdomen, thigh, upper outer arm) produce equivalent absorption. Rotate sites to reduce local skin and fat tissue irritation. Many people stay with the abdomen because it is easiest to pinch and the needle is least uncomfortable there.
How do I store a compounded tirzepatide vial?: Refrigerate at 36 to 46 degrees Fahrenheit. Do not freeze. Once opened, most compounded vials are stable for 28 to 56 days depending on the pharmacy. Check the beyond-use date your pharmacy printed on the label, not a generic value from an online source.
My compounded vial concentration changed at refill. What do I do?: Stop. Do not draw the same number of units you drew last week. Re-do the math with the new concentration printed on the new label. If you are unsure, call the pharmacy and ask them to confirm the new units value for your prescribed mg dose.

What this article does not cover

This page is the conversion math for the 2.5 mg starting dose. Adjacent questions, like which compounding pharmacy has the lowest cash price, whether telehealth providers in specific states can ship to you, and whether tirzepatide is safe with specific medications or pre-existing conditions, have their own dedicated pages on this site. Use the search or the sidebar to find them. The math here is the same at every dose, just substitute your prescribed milligrams into the formula at the top of the page.